Casdin Partners Master Fund, L.P. 4
Accession 0000919574-25-005603
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 7:08 PM ET
Size
24.4 KB
Accession
0000919574-25-005603
Insider Transaction Report
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,901,062
Common Stock, $0.001 par value per share
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,901,062
Common Stock, $0.001 par value per share
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,901,062
Common Stock, $0.001 par value per share
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,901,062
Common Stock, $0.001 par value per share
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,901,062
Common Stock, $0.001 par value per share
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,901,062
Common Stock, $0.001 par value per share
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- 2,901,062
Common Stock, $0.001 par value per share
- Purchase
Common Stock, $0.001 par value per share
2025-09-03$1.27/sh+250,000$316,400→ 60,525,000 total(indirect: See footnote) - Purchase
Common Stock, $0.001 par value per share
2025-09-04$1.28/sh+250,000$319,350→ 60,775,000 total(indirect: See footnote)
- 2,901,062
Common Stock, $0.001 par value per share
- 2,744,219(indirect: See footnote)
Common Stock, $0.001 par value per share
- 13,939,637(indirect: See footnote)
Common Stock, $0.001 par value per share
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2414 to $1.2765. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F2]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC (the "GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin and the GP.
- [F3]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $1.2621 to $1.2930. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
- [F4]The securities are owned directly by Eli Casdin.
- [F5]The securities are owned directly by Casdin Private Growth Equity Fund II, L.P. (the "Equity Fund II") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund II, and (ii) Eli Casdin, the managing member of Casdin.
- [F6]The securities are owned directly by Casdin Private Growth Equity Fund, L.P. (the "Equity Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund, and (ii) Eli Casdin, the managing member of Casdin.
Documents
Issuer
STANDARD BIOTOOLS INC.
CIK 0001162194
Related Parties
1- filerCIK 0001534265
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 7:08 PM ET
- Size
- 24.4 KB